Hemodynamic Monitoring Devices Market To Reach $2.18 Billion By 2030

Hemodynamic Monitoring Devices Market Growth & Trends

The global hemodynamic monitoring devices market size is expected to reach USD 2.18 billion and expand at a CAGR of 5.2% by 2030, based on a new report by Grand View Research, Inc. The growth of the market is attributed to the growing cases of cardiovascular diseases (CVD) such as ischemic stroke, heart failure, and others. Moreover, the growing geriatric population across the globe propels the demand for hemodynamic monitoring devices.

According to OECD’s report in 2021, the life expectancy in lower-and-middle income Asian countries has increased by six years from 2000, while upper-middle-income countries have recorded a growth of four years in life expectancy. Moreover, by 2050 ten countries in Asia-Pacific are expected to be profiled as “aging societies,” while eleven countries are expected to be “super-aged societies.” In addition, NCBI estimated that more than half of CVD cases are recorded in the Asia-Pacific region.

The pandemic positively impacted the hemodynamic monitoring systems market. Many hospitals stated increased demand for hemodynamic monitoring during the pandemic due to COVID-19-induced symptoms. Hemodynamic monitoring devices were necessary to monitor cardiac function and blood flow in COVID-19 patients experiencing respiratory complications, as respiratory and cardiovascular systems are closely interconnected. In addition, sepsis & septic shock caused hemodynamic instability in COVID-19 patients; thereby, hemodynamic monitoring devices use was necessitated in hospitals and other care facilities.

In addition, the market for hemodynamic monitoring devices is aided by various strategic initiatives, such as venture capital funding. For instance, in July 2022, Retia Medical received USD 15 million in Series B funding to expand its commercial offerings and accelerate the development & commercialization of Argos hemodynamic monitor.

 Request a free sample copy or view report summary: Hemodynamic Monitoring Devices Market Report

Hemodynamic Monitoring Devices Market Report Highlights

• The global market in the healthcare market size was estimated at USD 1.47 billion in 2022 and is expected to reach USD 2.18 billion in 2030

• The global market is expected to grow at a compound annual growth rate of 5.2% from 2023 to 2030

• In 2022, North America dominated the market in terms of the revenue share of 41.1%. This growth can be attributed to the presence of significant players, technologically advanced healthcare ecosystem, and growing number of critically ill patients

• The non-invasive segment dominated the revenue share in 2022 and accounted for 55.1% in 2022 of the market

• By product, monitors dominated the market with a revenue share of 62.7% in 2022. However, the disposables segment is estimated to the fastest growing during the forecast period. It is due to the growing collaboration amongst the leading companies to enhance product performance and alleviate patient care

• Hospitals dominated the market with a revenue share of 42.6% in 2022 due to the availability of advanced infrastructure and industrial partnership with leading healthcare companies

Hemodynamic Monitoring Devices Market Segmentation

Grand View Research has segmented the segmented the global hemodynamic monitoring devices market based on system type, product, end-use and region:

Hemodynamic Monitoring Devices System Type Outlook (Revenue in USD Billion, 2018 - 2030)

• Invasive

• Minimally Invasive

• Non-Invasive

Hemodynamic Monitoring Devices Product Outlook (Revenue in USD Billion, 2018 - 2030)

• Disposables

• Monitors

Hemodynamic Monitoring Devices End-use Outlook (Revenue in USD Billion, 2018 - 2030)

• Hospitals

• Catheterization Labs

• Others

Hemodynamic Monitoring Devices Regional Outlook (Revenue in USD Billion 2018 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • U.K.

  • Germany

  • France

  • Italy

  • Spain

  • Sweden

  • Norway

  • Denmark

• Asia Pacific

  • China

  • Japan

  • India

  • Australia

  • Thailand

  • South Korea

• Latin America

  • Brazil

  • Mexico

  • Argentina

• Middle East and Africa

  • Saudi Arabia

  • South Africa

  • UAE

  • Kuwait

List of Key Players in the Hemodynamic Monitoring Devices Market

• Edwards Lifesciences Corporation

• GE HealthCare

• Baxter

• ICU Medical

• Koninklijke Philips N.V.

• Sramek BioDynamics, Inc.

• OsypkaCardiotek GmbH

• Deltex Medical Group

• Masimo